Amphista Therapeutics Limited Email Format

Biotechnology ResearchEngland, United Kingdom11-50 Employees

Amphista Therapeutics Limited is a biotechnology company focused on developing targeted protein degradation therapies to modulate disease-related protein levels. Its work aims to address limitations of traditional degrader approaches by expanding beyond a narrow set of protein degradation mechanisms, with the goal of delivering medicines for conditions with high unmet medical need. The company describes its platform as leveraging advances in targeted protein degradation to create treatments that can influence disease progression at the protein level, and it is pursuing preclinical and early clinical programs in areas such as BRD9 and SMARCA2 degradation. Based in Great Abington, England, Amphista operates within the biopharmaceutical research landscape and collaborates with scientific leadership from the University of Dundee, reflecting its roots in academia and translational science.

Sign up for free to view info

Company overview Employee directory